Trade CAPR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Capricor Therapeutics, Inc. (CAPR) is trading at US$9.64, down 4.14% today as of Aug 28, 13:58 EDT. The company has a market capitalisation of US$365.69M. Over the past 52 weeks, CAPR has traded between US$2.96 and US$40.37. On Syfe you can trade CAPR with $0 commission and add it to your watchlist.
| Previous close | US$10.06 |
|---|---|
| Market cap | US$365.69M |
| 52-week range | US$2.96 – US$40.37 |
| Volume | 12.01M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Year: 2002
Capricor Therapeutics, Inc. (CAPR) stock is trading at US$9.64, -4.14% from the previous close of US$10.06.
The market cap for Capricor Therapeutics, Inc. (CAPR) stock is approximately US$365.69M.
The 52-week high for Capricor Therapeutics, Inc. (CAPR) stock is US$40.37.
The 52-week low for Capricor Therapeutics, Inc. (CAPR) stock is US$2.96.
Capricor Therapeutics, Inc. (CAPR) does not currently pay a dividend.
Stay on top of CAPR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
